ACS Infectious Diseases: Unique chemistry journal names editor
WASHINGTON, July 10, 2014 — The American Chemical Society (ACS) announced today that Courtney Aldrich, Ph.D., will head the brand-new, web-only journal ACS Infectious Diseases as editor-in-chief. With the first issue slated for publication in January 2015, the pioneering journal will meet a growing demand for a place to publish top-notch chemistry-focused infectious diseases research.
“Our vision is to develop a journal focused on diseases with a strong emphasis on the basic science that advances the field and lays the foundation for the clinical sciences,” says Editor-in-Chief Aldrich. He is an associate professor of medicinal chemistry at the University of Minnesota.
ACS Infectious Diseases will be the first journal to highlight chemistry and its role in this multidisciplinary and collaborative research area — an area that usually is served by journals with a biology focus. But with the journal’s introduction, scientists like Aldrich, whose research focuses on discovering and developing new antibacterial agents for tuberculosis and multidrug resistant pathogens, will now have a high-quality chemistry journal in which they can publish their findings.
“Chemists have always played significant roles in infectious diseases starting with Louis Pasteur, who provided the first definitive evidence for the germ theory of diseases,” says Aldrich. “Today, chemical tools are increasingly used to study the fundamental biology of infectious diseases, including pathogenesis, host immunity and drug resistance.”
The time is right for a new journal that addresses this area of study. Infectious diseases are a major public health issue around the world. Every year, they are responsible for about one-third of all deaths — roughly 3.5 million people — according to the World Health Organization. Globally, over half a million people died from malaria, and about 1 million people died from tuberculosis in 2012. In the U.S., HIV, pneumonia and influenza are among the leading causes of infectious diseases deaths. New diseases are emerging, and those thought to be under control are re-emerging. Microbial resistance to known drugs is increasing, leaving physicians with few or no choices for treating many patients.
“ACS Infectious Diseases will further broaden the scientific depth and breadth of ACS journals by providing an important publishing outlet for chemists and affiliated scientists working in this vitally important area,” says Susan King, Ph.D., senior vice president of the ACS Journals Publishing Group. “We look forward to working with Dr. Aldrich to make the new journal a success.”
Key research areas for the monthly journal include:
- Chemistry and bioactivity of antivirals, antibiotics and antiprotozoal agents
- Mechanisms of action and drug resistance
- Host-pathogen interactions
- Characterization and validation of drug targets
- Small-molecule antiviral adjuvants for vaccines
Manuscript submission will open in September.
For interviews and additional information, please contact email@example.com.
The American Chemical Society is a nonprofit organization chartered by the U.S. Congress. With more than 161,000 members, ACS is the world’s largest scientific society and a global leader in providing access to chemistry-related research through its multiple databases, peer-reviewed journals and scientific conferences. Its main offices are in Washington, D.C., and Columbus, Ohio.